Canopy Partners LLC Buys 401 Shares of Intuitive Surgical, Inc. $ISRG

Canopy Partners LLC lifted its stake in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 48.8% during the 2nd quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 1,222 shares of the medical equipment provider’s stock after buying an additional 401 shares during the quarter. Canopy Partners LLC’s holdings in Intuitive Surgical were worth $664,000 as of its most recent filing with the Securities & Exchange Commission.

Several other institutional investors have also recently made changes to their positions in ISRG. Chilton Capital Management LLC raised its stake in shares of Intuitive Surgical by 614.3% in the first quarter. Chilton Capital Management LLC now owns 50 shares of the medical equipment provider’s stock worth $25,000 after buying an additional 43 shares during the period. Elite Financial Inc. bought a new position in shares of Intuitive Surgical in the first quarter worth about $26,000. LFA Lugano Financial Advisors SA bought a new position in shares of Intuitive Surgical in the first quarter worth about $30,000. TD Capital Management LLC raised its stake in shares of Intuitive Surgical by 300.0% in the first quarter. TD Capital Management LLC now owns 60 shares of the medical equipment provider’s stock worth $30,000 after buying an additional 45 shares during the period. Finally, 1248 Management LLC bought a new position in shares of Intuitive Surgical in the first quarter worth about $30,000. Institutional investors own 83.64% of the company’s stock.

Analyst Upgrades and Downgrades

ISRG has been the topic of several recent analyst reports. Truist Financial lifted their target price on Intuitive Surgical from $590.00 to $600.00 and gave the company a “buy” rating in a research note on Wednesday, July 23rd. Wall Street Zen raised Intuitive Surgical from a “hold” rating to a “buy” rating in a research note on Saturday. Erste Group Bank reissued a “hold” rating on shares of Intuitive Surgical in a research note on Wednesday, July 23rd. Wells Fargo & Company lifted their target price on Intuitive Surgical from $559.00 to $599.00 and gave the company an “overweight” rating in a research note on Wednesday, July 23rd. Finally, BTIG Research reissued a “buy” rating and set a $571.00 target price on shares of Intuitive Surgical in a research note on Wednesday, October 1st. Fourteen investment analysts have rated the stock with a Buy rating, seven have given a Hold rating and one has given a Sell rating to the company. According to MarketBeat, the company currently has a consensus rating of “Moderate Buy” and a consensus price target of $589.43.

Intuitive Surgical Price Performance

NASDAQ ISRG opened at $440.94 on Wednesday. The stock has a market capitalization of $158.07 billion, a PE ratio of 61.50, a P/E/G ratio of 4.71 and a beta of 1.61. The business has a 50 day simple moving average of $461.55 and a two-hundred day simple moving average of $499.41. Intuitive Surgical, Inc. has a 1-year low of $425.00 and a 1-year high of $616.00.

Intuitive Surgical (NASDAQ:ISRG) last released its quarterly earnings results on Tuesday, July 22nd. The medical equipment provider reported $2.19 earnings per share for the quarter, beating the consensus estimate of $1.93 by $0.26. The business had revenue of $2.44 billion during the quarter, compared to analysts’ expectations of $2.35 billion. Intuitive Surgical had a return on equity of 14.56% and a net margin of 28.51%.The firm’s revenue for the quarter was up 21.4% compared to the same quarter last year. During the same quarter last year, the business posted $1.78 EPS. On average, analysts anticipate that Intuitive Surgical, Inc. will post 6.43 EPS for the current fiscal year.

Insider Buying and Selling at Intuitive Surgical

In other Intuitive Surgical news, Director Amy L. Ladd sold 336 shares of the firm’s stock in a transaction that occurred on Wednesday, September 3rd. The stock was sold at an average price of $470.11, for a total transaction of $157,956.96. Following the completion of the transaction, the director owned 1,074 shares in the company, valued at $504,898.14. This trade represents a 23.83% decrease in their position. The transaction was disclosed in a filing with the SEC, which is available through this link. Also, EVP Myriam Curet sold 4,500 shares of the firm’s stock in a transaction that occurred on Friday, July 25th. The shares were sold at an average price of $492.48, for a total value of $2,216,160.00. Following the transaction, the executive vice president owned 353 shares of the company’s stock, valued at $173,845.44. This represents a 92.73% decrease in their position. The disclosure for this sale can be found here. Insiders sold 45,224 shares of company stock worth $21,716,492 in the last quarter. 0.70% of the stock is owned by corporate insiders.

Intuitive Surgical Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.